ArticleThe Journal of clinical investigation2016

Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.

Jianing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.